– UK, Northwich – Dechra Pharmaceuticals PLC (LON: DPH) today announced the appointment of Dr. Lawson Macartney as Senior Independent Director with effect from 1 March 2022, following the appointment of Alison Platt as Chair of the Board of Directors on 1 January 2022.
About Dechra Pharmaceuticals PLC
Dechra is a global specialist in veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture marketing, and sales of high-quality products exclusively for veterinarians worldwide. Dechra’s business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.
For more information: https://www.dechra.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
